T1	PROC 1 35	Estudio aleatorizado y doble ciego
#1	AnnotatorNotes T1	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T2	PROC 39 49	profilaxis
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	ANAT 102 110	cardíaca
#3	AnnotatorNotes T3	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T4	DISO 82 90	sangrado
#4	AnnotatorNotes T4	C0019080; Hemorrhage; Pathologic Function
T5	PROC 94 110	cirugía cardíaca
#5	AnnotatorNotes T5	C0018821; Cardiac Surgery procedures; Therapeutic or Preventive Procedure
T6	DISO 143 153	hemorragia
#6	AnnotatorNotes T6	C0019080; Hemorrhage; Pathologic Function
T7	PROC 291 333	cirugía de revascularización del miocardio
#7	AnnotatorNotes T7	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T8	PROC 343 390	estudio prospectivo, aleatorizado y doble ciego
#8	AnnotatorNotes T8	C0013072; Double-Blind Method; Research Activity + C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T9	CHEM 450 476	concentrado de fibrinógeno
#9	AnnotatorNotes T9	C2587184; fibrinogen concentrate (human); Amino Acid, Peptide, or Protein · Pharmacologic Substance
T10	DISO 486 494	sangrado
#10	AnnotatorNotes T10	C0019080; Hemorrhage; Pathologic Function
T11	PROC 599 641	cirugía de revascularización del miocardio
#11	AnnotatorNotes T11	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T12	CHEM 711 722	fibrinógeno
#12	AnnotatorNotes T12	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T13	CHEM 741 767	concentrado de fibrinógeno
#13	AnnotatorNotes T13	C2587184; fibrinogen concentrate (human); Amino Acid, Peptide, or Protein · Pharmacologic Substance
T14	PROC 787 796	operación
#14	AnnotatorNotes T14	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T15	PROC 844 851	placebo
#15	AnnotatorNotes T15	C0032042; Placebos; Therapeutic or Preventive Procedure
T16	DISO 870 878	sangrado
#16	AnnotatorNotes T16	C0019080; Hemorrhage; Pathologic Function
T17	PROC 901 922	tiempo de protrombina
#17	AnnotatorNotes T17	C0033707; Prothrombin time assay; Laboratory Procedure
T18	PROC 924 956	tiempo de tromboplastina parcial
#18	AnnotatorNotes T18	C0030605; Activated Partial Thromboplastin Time measurement; Laboratory Procedure
T19	PROC 958 961	INR
#19	AnnotatorNotes T19	C0525032; International Normalized Ratio; Laboratory Procedure
T20	CHEM 977 990	hemoderivados
#20	AnnotatorNotes T20	C0456388; Blood product; Pharmacologic Substance | C1629497; Blood derivative; Pharmacologic Substance
T21	PROC 1073 1082	protocolo
#21	AnnotatorNotes T21	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T22	PROC 1112 1135	transfusión de hematíes
#22	AnnotatorNotes T22	C0086252; Red Blood Cell Transfusion; Therapeutic or Preventive Procedure
T23	CHEM 1210 1234	concentrados de hematíes
#23	AnnotatorNotes T23	C2316467; Packed red blood cells; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T24	CHEM 1281 1292	fibrinógeno
#24	AnnotatorNotes T24	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T25	CHEM 1336 1347	fibrinógeno
#25	AnnotatorNotes T25	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T26	DISO 1363 1371	sangrado
#26	AnnotatorNotes T26	C0019080; Hemorrhage; Pathologic Function
T27	CHEM 1462 1473	fibrinógeno
#27	AnnotatorNotes T27	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T28	CHEM 1521 1544	concentrado de hematíes
#28	AnnotatorNotes T28	C2316467; Packed red blood cells; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T29	DISO 1586 1603	evento trombótico
#29	AnnotatorNotes T29	C2674163; Thrombotic episodes; Finding
T30	PROC 1671 1681	profilaxis
#30	AnnotatorNotes T30	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T31	DISO 1708 1716	sangrado
#31	AnnotatorNotes T31	C0019080; Hemorrhage; Pathologic Function
T32	PROC 1771 1802	revascularización del miocardio
#32	AnnotatorNotes T32	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T33	CHEM 54 65	fibrinógeno
#33	AnnotatorNotes T33	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T34	ANAT 324 333	miocardio
#34	AnnotatorNotes T34	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T35	PROC 418 445	administración profiláctica
#35	AnnotatorNotes T35	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure | C4039267; Administration of prophylactic treatment; Therapeutic or Preventive Procedure
T36	PROC 509 551	cirugía de revascularización del miocardio
#36	AnnotatorNotes T36	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T37	ANAT 542 551	miocardio
#37	AnnotatorNotes T37	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T38	ANAT 632 641	miocardio
#38	AnnotatorNotes T38	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T39	PROC 649 673	aleatoriamente divididos
#39	AnnotatorNotes T39	C0034656; Randomization; Research Activity
T40	CHEM 911 922	protrombina
#40	AnnotatorNotes T40	C0033706; prothrombin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T41	CHEM 934 948	tromboplastina
#41	AnnotatorNotes T41	C0040048; Thromboplastin; Amino Acid, Peptide, or Protein · Immunologic Factor
T42	PROC 963 974	hemoglobina
#42	AnnotatorNotes T42	C0518015; Hemoglobin measurement; Laboratory Procedure
T43	PROC 991 1004	transfundidos
#43	AnnotatorNotes T43	C1879316; Transfusion (procedure); Therapeutic or Preventive Procedure
T44	ANAT 1127 1135	hematíes
#44	AnnotatorNotes T44	C0014792; Erythrocytes; Cell
T45	PROC 1196 1234	infusiones de concentrados de hematíes
#45	AnnotatorNotes T45	C0199962; Transfusion of packed red blood cells; Therapeutic or Preventive Procedure
T46	ANAT 1226 1234	hematíes
#46	AnnotatorNotes T46	C0014792; Erythrocytes; Cell
T47	PROC 1509 1544	infusión de concentrado de hematíes
#47	AnnotatorNotes T47	C0199962; Transfusion of packed red blood cells; Therapeutic or Preventive Procedure
T48	ANAT 1536 1544	hematíes
#48	AnnotatorNotes T48	C0014792; Erythrocytes; Cell
T49	PROC 1645 1652	cirugía
#49	AnnotatorNotes T49	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T50	CHEM 1686 1697	fibrinógeno
#50	AnnotatorNotes T50	C0016006; fibrinogen; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T51	ANAT 1793 1802	miocardio
#51	AnnotatorNotes T51	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T52	Date 160 182	período postoperatorio
#52	AnnotatorNotes T52	C0032790; Postoperative Period; Temporal Concept
T54	LIVB 269 278	pacientes
#53	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 577 586	pacientes
#54	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 691 700	pacientes
#55	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Dose 734 737	1 g
T58	Duration 768 774	30 min
T59	LIVB 819 832	grupo control
#56	AnnotatorNotes T59	C0009932; Control Groups; Group
T60	Date 885 899	postoperatorio
#57	AnnotatorNotes T60	C0032790; Postoperative Period; Temporal Concept
T61	LIVB 1053 1062	pacientes
#58	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T63	LIVB 1311 1324	grupo control
#59	AnnotatorNotes T63	C0009932; Control Groups; Group
T64	Date 1378 1392	postoperatorio
#60	AnnotatorNotes T64	C0032790; Postoperative Period; Temporal Concept
T65	LIVB 1442 1451	pacientes
#61	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 1483 1496	grupo control
#62	AnnotatorNotes T66	C0009932; Control Groups; Group
T67	Route 1509 1517	infusión
#63	AnnotatorNotes T67	C1621368; Intravenous Drip Route of Administration; Functional Concept
T68	Date 1551 1565	postoperatorio
#64	AnnotatorNotes T68	C0032790; Postoperative Period; Temporal Concept
T69	Neg_cue 1579 1585	Ningún
T70	Duration 1626 1630	72 h
T71	Date 1723 1745	período postoperatorio
#65	AnnotatorNotes T71	C0032790; Postoperative Period; Temporal Concept
T72	LIVB 1749 1758	pacientes
#66	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
A1	Assertion T29 Negated
T53	Neg_cue 1151 1153	no
T62	CONC 1159 1170	diferencias
A2	Assertion T62 Negated
#67	AnnotatorNotes T62	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T53 Arg2:T62	
R2	Negation Arg1:T69 Arg2:T29	
T73	Spec_cue 216 221	puede
T74	Observation 250 265	morbimortalidad
A3	Assertion T74 Speculated
R3	Used_for Arg1:T33 Arg2:T2	
R4	Location_of Arg1:T3 Arg2:T5	
R5	Causes Arg1:T5 Arg2:T4	
R7	Before Arg1:T2 Arg2:T4	
R8	Overlap Arg1:T6 Arg2:T52	
R9	Before Arg1:T6 Arg2:T74	
R10	Speculation Arg1:T73 Arg2:T74	
R11	Experiences Arg1:T54 Arg2:T74	
R12	Experiences Arg1:T54 Arg2:T6	
R13	Location_of Arg1:T34 Arg2:T7	
R14	Experiences Arg1:T54 Arg2:T7	
R15	Causes Arg1:T7 Arg2:T6	
R16	Location_of Arg1:T37 Arg2:T36	
T76	Observation 405 411	efecto
#69	AnnotatorNotes T76	C1518681; Outcome of Therapy; Finding (?)
R17	Causes Arg1:T35 Arg2:T76	
R18	Used_for Arg1:T9 Arg2:T35	
R19	Causes Arg1:T36 Arg2:T10	
R20	Before Arg1:T35 Arg2:T10	
R21	Experiences Arg1:T55 Arg2:T11	
R22	Location_of Arg1:T38 Arg2:T11	
R23	Before Arg1:T39 Arg2:T11	
R24	Experiences Arg1:T56 Arg2:T12	
R25	Has_Dose_or_Strength Arg1:T12 Arg2:T57	
R26	Has_Dose_or_Strength Arg1:T13 Arg2:T57	
R27	Has_Duration_or_Interval Arg1:T13 Arg2:T58	
R28	Before Arg1:T12 Arg2:T14	
R29	Before Arg1:T13 Arg2:T14	
R30	Experiences Arg1:T59 Arg2:T15	
R31	Before Arg1:T15 Arg2:T14	
R32	Experiences Arg1:T59 Arg2:T14	
T77	CONC 857 878	volúmenes de sangrado
R33	Overlap Arg1:T16 Arg2:T60	
R34	Overlap Arg1:T77 Arg2:T60	
R35	Used_for Arg1:T20 Arg2:T43	
R36	Overlap Arg1:T20 Arg2:T60	
R37	Overlap Arg1:T42 Arg2:T60	
R38	Overlap Arg1:T19 Arg2:T60	
R39	Overlap Arg1:T18 Arg2:T60	
R40	Overlap Arg1:T17 Arg2:T60	
R41	Experiences Arg1:T61 Arg2:T22	
T78	Quantifier_or_Qualifier 1083 1103	de conducta riguroso
R43	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T78	
R45	Used_for Arg1:T23 Arg2:T45	
R46	Experiences Arg1:T63 Arg2:T45	
R47	Overlap Arg1:T26 Arg2:T64	
R48	Before Arg1:T25 Arg2:T26	
R49	Experiences Arg1:T65 Arg2:T27	
R50	Experiences Arg1:T66 Arg2:T47	
R51	Experiences Arg1:T65 Arg2:T47	
R52	Has_Route_or_Mode Arg1:T28 Arg2:T67	
R53	Used_for Arg1:T28 Arg2:T47	
R55	Overlap Arg1:T28 Arg2:T68	
R56	Before Arg1:T27 Arg2:T47	
R57	Has_Duration_or_Interval Arg1:T29 Arg2:T70	
R58	After Arg1:T29 Arg2:T49	
R59	Used_for Arg1:T50 Arg2:T30	
R61	Overlap Arg1:T31 Arg2:T71	
R62	Experiences Arg1:T72 Arg2:T32	
R63	Location_of Arg1:T51 Arg2:T32	
R64	Experiences Arg1:T72 Arg2:T31	
R65	Experiences Arg1:T72 Arg2:T30	
R66	Before Arg1:T24 Arg2:T45	
T80	CONC 236 243	aumento
A4	Assertion T80 Speculated
#71	AnnotatorNotes T80	C0442805; Increase; Functional Concept
R67	Speculation Arg1:T73 Arg2:T80	
T81	Quantifier_or_Qualifier 1171 1185	significativas
A5	Assertion T81 Negated
#72	AnnotatorNotes T81	C0750502; Significant; Idea or Concept
R69	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T81	
R70	Negation Arg1:T53 Arg2:T81	
R6	Has_Duration_or_Interval Arg1:T15 Arg2:T58	
R60	Has_Dose_or_Strength Arg1:T15 Arg2:T57	
R42	Before Arg1:T30 Arg2:T31	
R44	Causes Arg1:T32 Arg2:T31	
R54	Overlap Arg1:T43 Arg2:T60	
R68	Before Arg1:T30 Arg2:T32	
A6	Experiencer T66 Patient
A7	Experiencer T65 Patient
A8	Experiencer T63 Patient
A9	Experiencer T72 Patient
A10	Experiencer T54 Patient
A11	Experiencer T55 Patient
A12	Experiencer T56 Patient
A13	Experiencer T59 Patient
A14	Experiencer T61 Patient
